Centessa Pharmaceuticals plc
CNTADelisted Jun 24, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847903
Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.
13F holders, Q2 2026
Institutional positions in Centessa Pharmaceuticals plc as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
CNTA is no longer listed, and 13F filings after Q1 2026 list far fewer holders. See Q1 2026
- Institutional holders
- 0
- −159 vs. Q1 2026
- Shares held
- 0
- −145.1M (−100.0%) vs. Q1 2026
- Total value
- $0
- −$5.76B (−100.0%) vs. Q1 2026
- New holders
- 0
- 0 more added
- Sold out
- 159
- 0 more reduced
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 161 | $5.90B |
| Q4 2025 | 147 | $3.60B |
| Q3 2025 | 125 | $3.11B |
| Q2 2025 | 117 | $1.62B |
| Q1 2025 | 130 | $1.80B |
| Q4 2024 | 114 | $2.08B |
| Q3 2024 | 103 | $1.74B |
| Q2 2024 | 80 | $781.2M |
| Q1 2024 | 69 | $840.7M |
| Q4 2023 | 58 | $567.4M |
| Q3 2023 | 49 | $469.6M |
| Q2 2023 | 45 | $435.4M |
| Q1 2023 | 44 | $257.5M |
| Q4 2022 | 44 | $194.4M |
| Q3 2022 | 44 | $288.7M |
| Q2 2022 | 41 | $350.3M |
| Q1 2022 | 44 | $669.1M |
| Q4 2021 | 47 | $807.8M |
| Q3 2021 | 40 | $947.5M |
| Q2 2021 | 50 | $1.05B |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Centessa Pharmaceuticals plc; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Yakira Capital Management, Inc. | 0 | $0 | 0.00% | −24,000−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −21,225−100.0% | Sold out |
| JBF Capital, Inc. | 0 | $0 | 0.00% | −20,887−100.0% | Sold out |
| Fortress Investment Group LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Torno Capital, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Crossmark Global Holdings, Inc. | 0 | $0 | 0.00% | −19,436−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −18,113−100.0% | Sold out |
| Meridian Wealth Partners, LLC | 0 | $0 | 0.00% | −18,101−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −17,737−100.0% | Sold out |
| Gabelli Funds LLC | 0 | $0 | 0.00% | −17,600−100.0% | Sold out |
| CSS LLC | 0 | $0 | 0.00% | −17,000−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −16,893−100.0% | Sold out |
| TD Waterhouse Canada Inc. | 0 | $0 | 0.00% | −15,595−100.0% | Sold out |
| Greenland Capital Management LP | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −13,965−100.0% | Sold out |
| Coastal Bridge Advisors, LLC | 0 | $0 | 0.00% | −13,102−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −12,699−100.0% | Sold out |
| Atria Investments LLC | 0 | $0 | 0.00% | −12,332−100.0% | Sold out |
| DnB Asset Management AS | 0 | $0 | 0.00% | −10,394−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −14,913−100.0% | Sold out |
| Virtus Investment Advisers, Inc. | 0 | $0 | 0.00% | −10,286−100.0% | Sold out |
| Gabelli & Co Investment Advisers, Inc. | 0 | $0 | 0.00% | −9,400−100.0% | Sold out |
| Bellevue Group AG | 0 | $0 | 0.00% | −9,030−100.0% | Sold out |
| Rangeley Capital, LLC | 0 | $0 | 0.00% | −9,000−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −8,303−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −8,298−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −7,034−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −6,991−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −6,975−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −6,922−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −6,900−100.0% | Sold out |
| BBR Partners, LLC | 0 | $0 | 0.00% | −6,551−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −6,238−100.0% | Sold out |
| Private Advisor Group, LLC | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −5,964−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −5,351−100.0% | Sold out |
| Empirical Asset Management, LLC | 0 | $0 | 0.00% | −5,083−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −3,980−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −3,081−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −2,482−100.0% | Sold out |
| GF Fund Management Co. Ltd. | 0 | $0 | 0.00% | −2,166−100.0% | Sold out |
| Bayforest Capital Ltd | 0 | $0 | 0.00% | −1,947−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,164−100.0% | Sold out |
| Adirondack Trust Co | 0 | $0 | 0.00% | −925−100.0% | Sold out |
| J.Safra Asset Management Corp | 0 | $0 | 0.00% | −397−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −277−100.0% | Sold out |
| Basecamp Wealth Advisors LLC | 0 | $0 | 0.00% | −128−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −81−100.0% | Sold out |
| NBC Securities, Inc. | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −41−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Aspect Partners, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| SJS Investment Consulting Inc. | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Janus Henderson Group PLC | – | – | – | – | Not filed |
| Skopos Labs, Inc. | – | – | – | – | Not filed |